IMMUNOLOGY MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Rising Health Expenditure and Improving Access to Care

Rising health expenditure globally can drive the market growth. Rising disposable incomes, growing focus on healthcare, increasing medical insurance penetration and better access to healthcare facilities have enabled more patients to afford and qualify for expensive procedures such as immunology market. In developed nations, the overall rise in per capita healthcare spending supports ongoing technological advancements and innovations to improve success rates of organ transplantation. Developing markets, which account for the majority of the disease burden, are witnessing increased expenditures on complex transplant surgeries. This is primarily attributed to extensive primary market research over time by governments and private organizations to elevate standards of medical care and make healthcare affordable for greater population. Consequently, more patients worldwide now have access to various stages of immunology market including pre-transplant evaluation, immunosuppressive therapy post transplantation and long-term medical management, thus, boosting demand for related services, devices and drugs. In January 2023, according to the report published by American Cancer Society, there will be over 27.5 million new cancer cases and 16.3 million deaths by 2040 due to population growth and aging. Risk factors like smoking and poor diet are rising, especially in developing nations, and this increases disease burden. Pharmaceutical firms are intensifying R&D for innovative drugs amidst the surge in chronic diseases.